OKYO Pharma OKYO
NASDAQ OKYO
$1.40 +0.12 (+9.38%)
As of: Nov 10, 2026 · 2:42 PM EST

OKYO Pharma (OKYO) Current Leases (2021)

Updated

OKYO Pharma (OKYO) posted Current Leases of $34.15 billion for the quarter ended Mar 31, 2021.

Analysis

OKYO Pharma (OKYO) Current Leases (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 OKYO Pharma 1.37 Bn 1.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 34.15 Bn
API Access

OKYO Pharma Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=OKYO&period=max&api_key=YOUR_API_KEY